Cite
HARVARD Citation
Liu, C. et al. (2022). A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer. Thoracic cancer. 13 (10), pp. 1463-1470. [Online].